What is the role for the neuroprotective agent memantine in patients receiving whole brain radiation therapy for brain metastases? Dr. Vivek Mehta reviews current practices to minimize risk of cognitive problems.
Please feel free to offer comments and raise questions in our Discussion Forums.
I see number of patients that are going to need whole brain radiation for multiple brain metastasis in the brain, and one of the questions that has come up recently is, “is there anything out there we can do to reduce the cognitive impairment that’s associated with whole brain radiation?”
Well, just a short while ago, we learned some really interesting, but preliminary, results on using a medicine called memantine. It’s actually a medicine that’s often used in Alzheimer's disease, but it was done in a study where patients who were receiving whole brain radiation either got this medication, or didn’t get this medication. The results of the study suggest that there may be a benefit in terms of preventing the onset of cognitive impairment if you get this medicine.
Now, this is one of the very first studies, and it’s a relatively small study — it probably needs to be duplicated with a larger number of patients, it probably needs to be done in more stringent fashion, to really see and tease out whether this really works. I’ll tell you that, from a radiation oncology community, there’s a fair bit of excitement about this, because we want to do anything we can to potentially reduce this particular complication, because, in the patients that get this disease and survive for a long period of time, we want to keep their mental status as high as possible.
In my clinic, when I see patients that bring this up, we often try to get this medication. One of the challenges that we have encountered is that insurance companies are not authorizing this for payment in this particular indication, and a medication, if you are buying it on your own, is awfully expensive.
So, we have not had as much success as we’d like, or the clinical experience in seeing patients truly benefit from this. It would be nice to see more studies, more data, and then convince the payers that this actually works, and that this should be moving into the standard of care. But I don’t think, today, that it’s something that we routinely offer to our patients because of these impediments.
Thought I should add that I am 65, former 30 yr smoker quit 8 yrs ago. Otherwise active and decent health. I will welcome any insight/answers to my questions whether to...
Hi and welcome to Grace,
I'm sorry you're going through this scare. I can't say if the 7mm growth in 7 years will or won't be a problem in the rather...
How does this forum work. Are community members able to reply to posts, or just moderators? Thanks
Usually the conversation is between the op and mod and/or faculty though we would like to have other members join in to share experiences, knowledge, and support. more heads are better...
Hi Michel, Welcome to Grace though I'm very sorry you are here.
Blood/liquid biopsies can detect cancer cells but usually only if there are a lot of cancer cells circulating. So...